Sponge-in-a-Pill could revolutionize early cancer detection
NCT ID NCT04214119
Summary
This study is testing a simple, swallowable sponge capsule called EsophaCap to collect cell samples from the esophagus and stomach. Researchers aim to find biological markers that can identify early signs of Barrett's esophagus, esophageal cancer, and stomach cancer. The goal is to develop a less invasive screening method to catch these cancers earlier when they are most treatable.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bayview Medical Center
RECRUITINGBaltimore, Maryland, 21205, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Johns Hopkins Hospital
RECRUITINGBaltimore, Maryland, 21205, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.